Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practice
{{output}}
BackgroundDrug-sparing antiretroviral treatment (ART) regimens are gaining interest in the treatment of HIV-1. Dolutegravir (DTG), a second-generation integrase inhibitor, has been pivotal in this development, allowing treatment with fewer drugs while maintain... ...
